James Trevaskis

James Trevaskis

Company: Gilead

Job title: Senior Director of Biology & Head of Fibrosis Research


Harnessing the Power of Preclinical NASH Models to Strategically Predict & Improve Clinical Outcomes & Therapeutic Response 11:00 am

• Highlighting preclinical rodent models of NASH and liver fibrosis, and ex vivo/in vitro systems modeling aspects of NASH/fibrosis. • Illustrating predictive capacity of preclinical models/systems to clinical efficacy by discussing ACC inhibitor/FXR agonism combination approach. • Investigating how to optimize preclinical NASH model use to strategically achieve a positive therapeutic responseRead more

day: Day 1 Stream 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.